Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares Issued
Ratios

Protagonist Therapeutics (PTGX) Shares Issued: 2017-2025

Historic Shares Issued for Protagonist Therapeutics (PTGX) over the last 9 years, with Sep 2025 value amounting to $5.7 million.

  • Protagonist Therapeutics' Shares Issued fell 53.04% to $5.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $24.5 million, marking a year-over-year increase of 9.39%. This contributed to the annual value of $26.5 million for FY2024, which is 75.46% down from last year.
  • Per Protagonist Therapeutics' latest filing, its Shares Issued stood at $5.7 million for Q3 2025, which was up 93.47% from $2.9 million recorded in Q2 2025.
  • Protagonist Therapeutics' 5-year Shares Issued high stood at $121.4 million for Q3 2021, and its period low was -$166,000 during Q4 2021.
  • For the 3-year period, Protagonist Therapeutics' Shares Issued averaged around $4.5 million, with its median value being $2.9 million (2025).
  • As far as peak fluctuations go, Protagonist Therapeutics' Shares Issued slumped by 111.44% in 2023, and later surged by 50,287.50% in 2024.
  • Over the past 5 years, Protagonist Therapeutics' Shares Issued (Quarterly) stood at -$166,000 in 2021, then soared by 433.13% to $553,000 in 2022, then crashed by 98.55% to $8,000 in 2023, then skyrocketed by 50,287.50% to $4.0 million in 2024, then plummeted by 53.04% to $5.7 million in 2025.
  • Its last three reported values are $5.7 million in Q3 2025, $2.9 million for Q2 2025, and $11.9 million during Q1 2025.